Codes / ICD10CM / T37.4X

T37.4X Poisoning by, adverse effect of and underdosing of anthelminthics

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of anthelminthics

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to anthelminthic medications, which are used to treat parasitic worm infections. It includes unintended toxic reactions, harmful side effects, or insufficient dosing of these agents, which may affect treatment efficacy or patient safety.

Causes

Poisoning or adverse effects can result from accidental or intentional overdose, incorrect administration, drug interactions, or allergic reactions to anthelminthics. Underdosing may occur due to subtherapeutic dosing, patient non-adherence, or formulation errors.

Risk Factors

  • Concurrent use of multiple medications increasing interaction risk.
  • Pre-existing renal or hepatic impairment affecting drug metabolism.
  • History of allergic reactions to similar drug classes.
  • Lack of proper medication monitoring or dosage adjustments.

Symptoms

  • Nausea, vomiting, or gastrointestinal distress.
  • Dizziness, confusion, or central nervous system effects.
  • Skin rashes, itching, or hypersensitivity reactions.
  • Signs of underdosing, such as unresolved parasitic infection or treatment failure.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, renal/hepatic function, or parasitological studies). Imaging or other studies may be used to assess organ involvement or infection persistence.

Treatment Options

Management depends on the severity and type of exposure. For poisoning, decontamination, supportive care, and specific antidotes (if available) may be used. Adverse effects often require discontinuation or dose adjustment of the anthelminthic. Underdosing may necessitate re-evaluation of the treatment regimen and patient adherence.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure, underlying health, and timely intervention. Follow-up includes monitoring for symptom resolution, organ function, and treatment efficacy. Long-term follow-up may be needed for chronic or severe cases.

Complications

  • Organ toxicity (e.g., hepatic or renal impairment).
  • Severe allergic reactions (e.g., anaphylaxis).
  • Treatment failure due to underdosing, leading to persistent infection.
  • Neurological or cardiovascular effects from toxic exposure.

Lifestyle & Prevention

  • Ensure proper storage and handling of anthelminthic medications to prevent accidental ingestion.
  • Follow prescribed dosing schedules and complete treatment courses to avoid underdosing.
  • Educate patients on potential side effects and when to seek medical attention.
  • Avoid self-medication or sharing medications to reduce overdose risk.

When to Seek Professional Help

Seek immediate medical care for symptoms of poisoning (e.g., severe nausea, confusion, or allergic reactions) or if underdosing is suspected (e.g., unresolved infection despite treatment). Prompt evaluation is critical for managing adverse effects or toxic exposure.

Tips for Medical Coders

Document the specific anthelminthic involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., overdose, interaction, or non-adherence). Ensure clinical details support the coded event to accurately reflect the patient's condition.

Book a walkthrough

T37.4X policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.